Pharmabiz6h
Curasight announces positive preclinical results with uTREAT in aggressive brain cancer
Curasight announces positive preclinical results with uTREAT in aggressive brain cancer: Copenhagen Thursday, June 8, 2023, 18:00 Hrs [IST] Curasight A/S, a clinical development c ...
Pharmabiz7h
Amarna Therapeutics appoints Dr Henk Streefkerk as new CEO
Amarna Therapeutics, a privately-held biotechnology company, announces the appointment of Dr Henk Streefkerk as the company’s new chief executive officer and medical director. He succeeds Steen ...
Pharmabiz8h
ECDC, EMA issue statement on updating Covid-19 vaccines to target new SARS-CoV-2 virus variants
ECDC, EMA issue statement on updating Covid-19 vaccines to target new SARS-CoV-2 virus variants: Amsterdam, The Netherlands Thursday, June 8, 2023, 16:00 Hrs [IST] The European Ce ...
Pharmabiz9h
US FDA announces availability of draft guidance with updated recommendations for GCPs aimed to modernize clinical trials
US FDA announces availability of draft guidance with updated recommendations for GCPs aimed to modernize clinical trials: Maryland Thursday, June 8, 2023, 15:00 Hrs [IST] The US F ...
Pharmabiz10h
Sankara Eye Hospital unveils retina reading centre ‘Sudarshan’
Sankara Eye Hospital, unveiled ‘Sudarshan’, a technology-enabled retinal image reading centre and the Shri V Venkata Reddy Block. The ophthalmic facility established in 2008 under the aegis of Sri ...
Pharmabiz11h
Connecta Therapeutics receives Spanish regulatory nod to begin phase I trials of CTH120 to treat Fragile X syndrome
Connecta Therapeutics receives Spanish regulatory nod to begin phase I trials of CTH120 to treat Fragile X syndrome: Barcelona, Spain Thursday, June 8, 2023, 13:00 Hrs [IST] Conne ...
Pharmabiz10h
US FDA grants De Novo authorization to Cue Health’s Covid-19 home use test
US FDA grants De Novo authorization to Cue Health’s Covid-19 home use test: San Diego, California Thursday, June 8, 2023, 14:00 Hrs [IST] Cue Health, a healthcare technology com ...
Pharmabiz15h
European Commission authorises GSK’s RSV vaccine, Arexvy for older adults
European Commission authorises GSK’s RSV vaccine, Arexvy for older adults: London, UK Thursday, June 8, 2023, 09:00 Hrs [IST] GSK plc announced that the European Commission has ...
Pharmabiz12h
GeneTex introduces PD-L1 antibody comprehensively validated by MS Validated Antibodies for immunohistochemistry
GeneTex introduces PD-L1 antibody comprehensively validated by MS Validated Antibodies for immunohistochemistry: Irvine, California Thursday, June 8, 2023, 12:00 Hrs [IST] GeneTex ...
Pharmabiz16h
Excipient industry deliberated on quality,compliance & role of excipients in enhancing drug quality at IPEC Conference
Excipient industry deliberated on quality,compliance & role of excipients in enhancing drug quality at IPEC Conference: Shardul Nautiyal, Mumbai Thursday, June 8, 2023, 08:00 Hrs ...
Pharmabiz16h
CDSCO declares sample of Bharat Biotech’s typhoid vaccine Typbar as NSQ
CDSCO declares sample of Bharat Biotech’s typhoid vaccine Typbar as NSQ: Gireesh Babu, New Delhi Thursday, June 8, 2023, 08:00 Hrs [IST] The Central Drugs Standard Control Organ ...
Pharmabiz14h
DURECT completes enrollment in phase 2b AHFIRM trial of larsucosterol in alcohol-associated hepatitis
DURECT Corporation, a biopharmaceutical company developing epigenetic therapies for the treatment of acute organ injuries and chronic liver diseases, announced that it has completed enrollment in its ...